Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | (Q1)Sep 30, 2023 | (FY)Jun 30, 2023 | (Q4)Jun 30, 2023 | (Q3)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | ||||||||||
| Cash from operating activities | -2,538.58%-57.33M | -26.43M | 47.42M | -390.17%-236.4M | -1.43%2.35M | 69.20%-4.46M | 264.59%18.62M | -49.99%-48.23M | 51.15%-24.83M | 283.04%2.39M |
| Net profit before non-cash adjustment | -540.64%-14.85M | ---21.9M | ---5.64M | -126.40%-46.51M | 67.41%-2.32M | 141.61%3.28M | -31.91%352K | 85.88%-20.55M | 92.29%-6.06M | 65.25%-7.11M |
| Total adjustment of non-cash items | 348.50%3.49M | --4.58M | --1.76M | 41.33%21.87M | -143.74%-1.4M | 20.64%3.9M | 20.50%3.12M | -79.67%15.48M | -25.96%6.44M | -13.52%3.21M |
| -Depreciation and amortization | ---- | ---- | ---- | 46.41%23.94M | ---- | ---- | ---- | -0.81%16.35M | ---- | ---- |
| -Reversal of impairment losses recognized in profit and loss | ---- | ---- | ---- | --0 | ---- | ---- | ---- | -96.64%2.03M | ---- | ---- |
| -Assets reserve and write-off | ---- | ---- | ---- | 151.70%411K | ---- | ---- | ---- | -143.97%-795K | ---- | ---- |
| -Disposal profit | ---- | ---- | ---- | 488.52%1.23M | ---- | ---- | ---- | 32.28%209K | ---- | ---- |
| -Other non-cash items | 348.50%3.49M | --4.58M | --1.76M | -59.68%-3.71M | -143.74%-1.4M | 20.64%3.9M | 20.50%3.12M | 19.08%-2.32M | 83.84%-11.36M | -13.52%3.21M |
| Changes in working capital | -856.96%-45.97M | ---9.11M | --51.29M | -390.65%-211.75M | -3.42%6.07M | -18.51%-11.64M | 205.03%15.14M | -215.79%-43.16M | -231.95%-25.21M | -59.31%6.29M |
| -Change in receivables | ---- | ---- | ---- | -768.97%-211.68M | ---- | ---- | ---- | 139.61%31.64M | ---- | ---- |
| -Change in inventory | ---- | ---- | ---- | -253.57%-6.59M | ---- | ---- | ---- | -142.19%-1.86M | ---- | ---- |
| -Change in payables | ---- | ---- | ---- | 108.93%6.51M | ---- | ---- | ---- | -164.69%-72.94M | ---- | ---- |
| -Changes in other current assets | -127.08%-15.33M | ---75.8M | --128.26M | ---- | 1,081.90%56.61M | -200.64%-25.74M | -58.25%19.41M | ---- | ---- | -88.09%4.79M |
| -Changes in other current liabilities | 39.37%-30.64M | --66.7M | ---76.97M | ---- | -3,473.83%-50.54M | 139.83%14.1M | 92.99%-4.27M | ---- | ---- | 106.04%1.5M |
| Dividends paid (cash flow from operating activities) | ||||||||||
| Dividends received (cash flow from operating activities) | ||||||||||
| Interest paid (cash flow from operating activities) | ||||||||||
| Interest received (cash flow from operating activities) | ||||||||||
| Tax refund paid | 0 | 0 | 0 | 0 | 0 | 0 | ||||
| Other operating cash inflow (outflow) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating cash flow | -2,538.58%-57.33M | ---26.43M | --47.42M | -390.17%-236.4M | -1.43%2.35M | 69.20%-4.46M | 264.59%18.62M | -49.99%-48.23M | 51.15%-24.83M | 283.04%2.39M |
| Investing cash flow | ||||||||||
| Net PPE purchase and sale | --0 | --0 | ---397K | -2,073.68%-51.78M | -98.29%-813K | 98.13%-32K | ---622K | 46.62%-2.38M | -755.00%-262K | 88.42%-410K |
| Interest received (cash flow from investment activities) | 1,097.67%429K | --467K | --425K | 37.70%3.94M | -106.13%-43K | -1.39%711K | -1.39%711K | -10.23%2.86M | -9.10%719K | -8.13%701K |
| Investing cash flow | 150.12%429K | --467K | --28K | -10,065.83%-47.84M | -394.16%-856K | 168.66%679K | -87.66%89K | 137.68%480K | -99.23%457K | 100.47%291K |
| Financing cash flow | ||||||||||
| Net issuance payments of debt | ---- | ---- | ---- | ---12.4M | --4.3M | ---- | ---- | --0 | --0 | --0 |
| Interest paid (cash flow from financing activities) | ---- | ---- | ---- | 57.25%-230K | 159.26%80K | 26.77%-93K | 0.00%-138K | -70.25%-538K | 0.00%-138K | 0.00%-135K |
| Financing cash flow | ---- | ---- | ---- | -2,247.58%-12.63M | 3,340.74%4.38M | -9,737.01%-12.49M | 0.00%-138K | -104.45%-538K | 0.00%-138K | 0.00%-135K |
| Net cash flow | ||||||||||
| Beginning cash position | -36.23%488.82M | --514.78M | --467.34M | -5.94%764.2M | -2.50%766.49M | -2.37%782.77M | -5.94%764.2M | -2.56%812.49M | -1.90%788.71M | -9.31%786.16M |
| Current changes in cash | -1,069.37%-56.9M | ---25.96M | --47.45M | -514.80%-296.86M | 131.01%5.87M | -4.35%-16.27M | 273.08%18.57M | -126.23%-48.29M | -388.27%-24.51M | 104.04%2.54M |
| End cash Position | -14.92%431.92M | --488.82M | --514.78M | -38.85%467.34M | -35.64%507.64M | -2.50%766.49M | -2.37%782.77M | -5.94%764.2M | -5.94%764.2M | -1.90%788.71M |
| Free cash flow | -3,849.57%-57.33M | ---26.43M | --47.02M | -469.82%-288.67M | -22.58%1.53M | 72.34%-4.49M | 259.00%17.98M | -38.15%-50.66M | 50.65%-25.09M | 140.76%1.98M |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.